Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2020-10-24 | 2020-10-24 |
| Drug Identification Number | 02324091 | 02324091 |
| Brand name | EPIRUBICIN FOR INJECTION | EPIRUBICIN FOR INJECTION |
| Common or Proper name | EPIRUBICIN FOR INJECTION 2mg/ml | EPIRUBICIN FOR INJECTION 2mg/ml |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients | EPIRUBICIN HYDROCHLORIDE | EPIRUBICIN HYDROCHLORIDE |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5ML | 5ML |
| ATC code | L01DB | L01DB |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2020-10-23 | 2020-10-23 |
| Actual discontinuation date | 2020-10-23 | 2020-10-23 |
| Remaining supply date | 2020-10-23 | 2020-10-23 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Discontinued as of Oct 23 2020 | Discontinued as of Oct 23 2020 |
| Health Canada comments |